IPAR · Interparfums, Inc. · Stock research

Current Thesis

The leg an investor was buying — a rotation bid into a licensed-fragrance compounder with a long-dated license book — has stopped being paid for growth. The 2026-08-04 print resolved the binary flagged in the prior read, and it resolved flat: Q2 EPS $0.95 against a $0.96 consensus, net sales $341.037M against $339.0M, FY2026 guidance reaffirmed at $1.480B sales and $4.85 GAAP EPS — both beneath the $1.503B and $4.87 the street carried into the day. Management reaffirmed instead of raising, and did so with a margin caveat attached: Simply Wall St's 2026-08-07 write-up tied a 5.2% post-report decline to higher marketing and logistics spend.

The sell-side sequence since is the more informative part. Canaccord Genuity's Susan Anderson reiterated Buy and lifted her target from $141 to $151 on 2026-08-06. Four sessions later, on 2026-08-10, TD Cowen's Jonna Kim cut to Hold while raising her target $110 → $120, and Goldman Sachs' Aron Adamski cut to Neutral while raising his $110 → $129. Two firms marked the number up and the recommendation down in the same session — a valuation reset applied to a company guiding EPS lower year on year.

Price stands at $114.63 (2026-08-14 close), 10.8% below the $128.55 52-week high, RSI(14) 34.8, still +34.1% over three months. The July extension has partly unwound without a break of the $110 shelf.

Bullish and bearish views on Interparfums, Inc.

The model's bull view on Interparfums, Inc. (IPAR), in brief: The guide floor held. FY2026 sales $1.480B and GAAP EPS $4.85 were affirmed on 2026-08-04 despite the Q2 EPS miss — the number the multiple rests on was not cut. Q2 net sales beat: $341.037M vs $339.0M consensus (2026-08-04 report), with net income of $30.49M for the quarter.… The bear view: Guidance is below consensus on both lines — $1.480B vs $1.503B and $4.85 vs $4.87 (2026-08-04) — and the affirmed EPS is a decline against 2025. Both cases follow in full.

Bull Case

• The guide floor held. FY2026 sales $1.480B and GAAP EPS $4.85 were affirmed on 2026-08-04 despite the Q2 EPS miss — the number the multiple rests on was not cut.
• Q2 net sales beat: $341.037M vs $339.0M consensus (2026-08-04 report), with net income of $30.49M for the quarter.
• The target set has crossed above spot for the first time in this leg. Stockanalysis (retrieved 2026-08-16) shows 5 analysts, average $131.60, low $113, high $151, consensus Buy — against a 2026-08-14 close of $114.63. In early July the average sat near $106 with the stock trading through it (MarketBeat 2026-07-10).
• Canaccord raised to $151 on 2026-08-06, i.e. after the print rather than into it, and kept a Buy.
• Named 2027 launch pipeline on the Q2 report: Montblanc, Coach, GUESS, Jimmy Choo, Longchamp, Off-White. The license book behind it is long-dated — Guess extended to 2048, 20-year Nautica and David Beckham agreements.
• Brand breadth in the 2026-07-22 preliminary sales release: Jimmy Choo +23%, Donna Karan/DKNY +28%, Ferragamo +41%, US net sales +18% in Q2.
• Cash return continues: $0.80 quarterly dividend declared 2026-08-04, record 2026-09-15, payable 2026-09-30.

Bear Case

• Guidance is below consensus on both lines — $1.480B vs $1.503B and $4.85 vs $4.87 (2026-08-04) — and the affirmed EPS is a decline against 2025. A +34.1% three-month move on falling guided earnings is multiple expansion.
• Two downgrades in one session (2026-08-10, TD Cowen and Goldman) is the clearest dated evidence that the institutional bid has moved from accumulation to valuation discipline.
• The anchor license is still shrinking: Lacoste fragrance sales -19% in Q2 and -16% in H1 (2026-07-22). Consolidated +2% growth depends on the rest of the portfolio covering that hole.
• Margin pressure is now on the record via the post-print commentary (marketing and logistics costs, Simply Wall St 2026-08-07), which is what turns a sales beat into an EPS miss.
• Coverage is thin — 5 analysts — so the $131.60 average is one $151 outlier away from collapsing toward the $113 low, which sits essentially at the current tape.
• The 2026-08-04 catalyst came and went without a raise. The next scheduled fundamental event is a quarter away, leaving the tape to trade on flow.

Setup & Price Structure

• 2026-08-14 close $114.63; 52-week high $128.55; drawdown from that high 10.8%; three-month return +34.1%; RSI(14) 34.8.
• The $110 area is the June–July breakout shelf identified in the prior read and remains the nearest structural reference below the current tape. It has not been broken on a weekly closing measure through 2026-08-14.
• The prior read placed the 90-day moving average near $97 in late July with price roughly 25% above it. That gap has compressed as price fell and the average rose; the extension has been worked off partly by time, partly by the 5.2% post-report drop.
• The narrative is saturated. What dates it — sell-side catch-up completed between 2026-07-23 (Canaccord $123→$141) and 2026-08-06 ($141→$151), i.e. entirely after the move; the same week delivered two rating cuts (2026-08-10); the binary print passed on 2026-08-04 with a below-consensus guide reaffirmed; and the drawdown to -10.8% off the high has been absorbed by targets rising rather than by fresh fundamental news.
• Positioning observables, stated as observables: RSI(14) at 34.8 says momentum has already flushed, so this is not a crowded-momentum condition at the 2026-08-14 close; but the three-month gain of +34.1% means holders are still sitting on a large unrealized advance, which is the fuel for supply on any further deterioration. No earnings date falls inside the next 30 days. No insider transactions appear in the filing record reviewed for this update. Two of five covering firms moved to the sidelines within one session.

Catalyst Calendar (next 30 days)

• 2026-09-15 — record/ex-dividend date for the $0.80 quarterly dividend declared 2026-08-04. This is the only dated company event inside the window and it resolves nothing about the growth guide.
• 2026-09-30 — dividend payable date.
• No scheduled fundamental catalyst. Q2 was reported 2026-08-04, so the next quarterly report falls outside 30 days; on the company's quarterly cadence that lands ~2026-11-04 (est., unconfirmed).

Elapsed catalysts

• Unscheduled but dated when it happens: further rating action from the three firms still positive after 2026-08-10. (passed 16d ago)

What Would Change Our Mind

What actually breaks the frame is the $110 shelf giving way on a weekly closing measure — that is the level the June–July breakout was built on, and losing it removes the last piece of structure between the current tape and the rising 90-day average that ran near $97 in late July. Stated gradeably: a weekly close below $110 ends the breakout leg. A second, independent break would be any trim to the affirmed $1.480B sales / $4.85 EPS FY2026 guide at the next report, or a third covering firm leaving Buy — the 2026-08-10 pair established that this coverage set moves together.

What would rebuild the constructive case, symmetrically: a weekly close back above $128.55 reclaims the 52-week high and would make the target catch-up look like a leading move after all; a Q3 report showing Lacoste stabilising in the mid-single-digit decline range or better would remove the largest fundamental hole. Absent either, the name is a low-conviction proposition for fresh entries at these levels — the catalyst is behind it and the next one is a quarter out.

Correlation Notes

• Do not conflate Interparfums, Inc. (NASDAQ: IPAR, USD reporting) with parent Interparfums SA (Euronext: ITP, EUR reporting). Euro-denominated revenue and EBIT guidance headlines belong to the parent and are not IPAR's numbers.
• European-based operations are a material share of consolidated sales (Europe-based net sales -4% in Q2, 2026-07-22), so USD/EUR moves flow into reported growth independent of demand.
• The business is a licensor's tenant, not a brand owner. Revenue durability is a function of contract terms (Guess to 2048, 20-year Nautica and Beckham deals) and of licensor decisions to renew or in-source — a different risk profile from owned-brand beauty comparables.
• Sits with the quality-defensive/consumer-staples rotation cohort; the drawdown since the late-July high has coincided with sell-side rotating the name from Buy to Hold rather than with a demand datapoint.